Zurich, Switzerland

Ernst Hafen


Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2003-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ernst Hafen: Innovator in Growth Regulation and Therapeutic Screening

Introduction

Ernst Hafen is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the areas of growth regulation and therapeutic screening methodologies. With a total of 2 patents, his work has implications for both medical diagnostics and gene therapy.

Latest Patents

One of Hafen's latest patents focuses on growth regulating proteins. This application discloses a new family of proteins known as epsin-like proteins (ELP). These proteins contain an ENTH domain (Epsin NH2 Terminal Homology domain) and exhibit growth-inhibiting activity. The proteins have potential applications in diagnosing hyperproliferative diseases and in gene therapy.

Another significant patent involves a function-based small molecular weight compound screening system in Drosophila melanogaster. This methodology allows for the screening of libraries of compounds for desirable biological or therapeutic activities. It utilizes an automated system for the microinjection of compounds into the open circulatory system of genetically modified Drosophila larvae. This innovative approach enables rapid identification of compounds that can selectively interfere with specific signaling pathways related to human diseases.

Career Highlights

Throughout his career, Ernst Hafen has worked with notable organizations, including The Genetics Company, Inc. and Universität Zürich. His research has contributed to advancements in understanding growth regulation and therapeutic applications.

Collaborations

Hafen has collaborated with esteemed colleagues such as Hugo Stocker and Pierre Daram, further enhancing the impact of his research in the scientific community.

Conclusion

Ernst Hafen's innovative work in growth regulation and therapeutic screening exemplifies the importance of research in biotechnology. His contributions continue to influence the fields of medical diagnostics and gene therapy, showcasing the potential of scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…